Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

The impact of the restatement on the Consolidated Balance sheets as of December 31, 2022 is presented below. (Details)

v3.24.1.1.u2
The impact of the restatement on the Consolidated Balance sheets as of December 31, 2022 is presented below. (Details)
Dec. 31, 2022
USD ($)
IfrsStatementLineItems [Line Items]  
Accrued expenses and other current liabilities $ 4,381,083
Contract liability (previously termed as Deferred revenue) 5,820,450
Previously stated [member]  
IfrsStatementLineItems [Line Items]  
Accrued expenses and other current liabilities 3,809,540
Contract liability (previously termed as Deferred revenue) 6,391,993
Increase (decrease) due to corrections of prior period errors [member]  
IfrsStatementLineItems [Line Items]  
Accrued expenses and other current liabilities 571,543
Contract liability (previously termed as Deferred revenue) $ (571,543)